Abstract
Defective intracellular antioxidant enzyme production (IAP) has been demonstrated in adults with diabetic nephropathy. To evaluate the effects on IAP of vitamin E administration in adolescents with type 1 diabetes and early signs of microangiopathy, 12 adolescents (aged 11–21 y; diabetes duration 10–18) were studied. Eight had retinopathy [background (four), preproliferative (three), or proliferative (one)], four had persistent microalbuminuria, and seven had both. Skin fibroblasts were obtained by biopsies and cultured in Dulbecco's modified Eagle's medium. CuZn superoxide dismutase (SOD), MnSOD, catalase (CAT), and glutathione-peroxidase (GPX) activity and mRNA expression were measured before and after 3 mo of synthetic vitamin E supplementation (600 mg twice daily); on both occasions, IAP was evaluated at different ex vivo glucose concentrations (5 and 22 mM). Ten adolescents with type 1 diabetes (aged 12–20 y) without angiopathy and eight healthy volunteers (aged 15–22 y) participated as control subjects. Vitamin E serum levels were measured throughout the study. In normal glucose concentrations, CuZnSOD, MnSOD, CAT, and GPX activity and mRNA expression were not different among the groups. In high glucose, CuZnSOD activity and mRNA increased similarly in all groups [angiopathics: 0.96 ± 0.30 U/mg protein; 9.9 ± 3.2 mRNA/glyceraldehyde-3-phosphate dehydrogenase). CAT and GPX activity and mRNA did not increase in high glucose only in adolescents with angiopathy (0.35 ± 0.09; 4.2 ± 0.1 and 0.52 ± 0.14; 2.4 ± 0.9, respectively). MnSOD did not change in any group. Vitamin E supplementation had no effect on any enzymatic activity and mRNA in both normal and hyperglycemic conditions. Adolescents with early signs of diabetic angiopathy have defective IAP and activity, which are not modified by vitamin E.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- CAT:
-
catalase
- DMEM:
-
Dulbecco's modified Eagle's medium
- GAPDH:
-
glyceraldehyde-3-phosphate dehydrogenase
- GPX:
-
glutathione-peroxidase
- SOD:
-
superoxide dismutase
- SSC:
-
standard sodium citrate
References
Baynes JW 1991 Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405–412
Ceriello A, Giugliano D 1997 Oxidative stress and diabetic complications. In: Alberti KGMM, Zimmet P, De Fronzo RA (eds) International Textbook of Diabetes Mellitus. John Wiley & Sons, Chichester, pp 1453–1461
Baynes JW, Thorpe SR 1996 The role of oxidative stress in diabetic complications. Current Opin Endocrinol 3: 277–284
Giugliano D, Ceriello A, Paolisso G 1996 Oxidative stress and diabetic vascular complications. Diabetes Care 19: 257–267
Ceriello A, dello Russo P, Amstad P, Cerutti P 1996 High glucose induces antioxidant enzymes in human endothelial cell in culture. Evidence linking hyperglycemia and oxidative stress. Diabetes 45: 471–477
Sechi LA, Ceriello A, Griffin CA, Catena C, Amstad P, Schambelan M, Bartoli E 1997 Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus. Diabetologia 40: 23–29
Reddi AS, Bollineni JS 1997 Renal cortical expression of mRNAs for antioxidant enzymes in normal and diabetic rats. Biochem Biophys Res Commun 235: 598–601
Mullarkey CJ, Edelstein D, Brownlee M 1990 Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 173: 932–939
Ceriello A, Quatraro A, Giugliano D 1992 New insight on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications. Diabet Med 9: 297–299
Wolff SP, Dean RT 1987 Glucose autooxidation and protein modification. The potential role of “autoxidative glycosylation” in diabetes. Biochem J 245: 243–250
DeRubertis FR, Craven PA 1994 Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 43: 1–8
Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, van den Enden M, Kilo C, Tilton RG 1993 Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42: 801–813
Ceriello A, Morocutti A, Mercuri F, Quagliaro L, Moro M, Damante G, Viberti GC 2000 Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 49: 2170–2177
Chiarelli F, Cipollone F, Mohn A, Marini M, Iezzi A, Tumini S, Fazia M, De Cesare D, Pomilio M, Pierdomenico SD, Cuccurullo F, Mezzetti A 2002 Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes. Diabetes Care 25: 1829–1834
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee 2003 The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289: 2560–2572
Task Force on Blood Pressure Control in Children; National Heart, Lung, and Blood Institute, Bethesda, Maryland 1987 Report of the Second Task Force on Blood Pressure Control in Children—1987. Pediatrics 79: 1–26
Chiarelli F, Cipollone F, Romano F, Tumini S, Costantini F, di Ricco L, Pomilio M, Pierdomenico SD, Marini M, Cuccurullo F, Mezzetti A 2000 Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes 49: 1258–1263
Mezzetti A, Guglielmi MD, Pierdomenico SD, Costantini F, Cipollone F, De Cesare D, Bucciarelli T, Ucchino S, Chiarelli F, Cuccurullo F, Romano F 1999 Increased systemic oxidative stress after elective endarterectomy: relation to vascular healing and remodeling. Arterioscler Thromb Vasc Biol 19: 2659–2665
Kearney JN 1991 Cryopreservation of cultured skin cells. Burns 17: 380–383
Bradford M 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254
Clairborne A 1985 Catalase activity. In: Greenwald R (ed) Handbook of Methods for Oxygen Radical Research, CRC Press, Boca Raton, pp 283–284
Gunzler W, Flohé L 1985 Glutathione peroxidase. In: Greenwald R (ed) Handbook of Methods for Oxygen Radical Research. CRC Press, Boca Raton, pp 285–290
Paoletti F, Aldinucci D, Mocali A, Caparrini A 1986 A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts. Anal Biochem 154: 536–541
Beauchamp B, Fridovich I 1971 Superoxide dismutase improved assays and an assay applicable to acrylamide gels. Anal Biochem 44: 276–287
Lemasters JJ, Grunwald R, Emaus RK 1984 Thermodynamic limits to the ATP/site stoichiometries of oxidative phosphorylation by rat liver mitochondria. J Biol Chem 259: 3058–3063
Chirgwin J, Przbyla A, MacDonald RJ, Rutter WJ 1979 Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294–5299
Amstad P, Peskin A, Shah G, Mirault ME, Moret R, Zbinden I, Cerutti P 1991 The balance between Cu, Zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochemistry 30: 9305–9313
Ho YS, Crapo JD 1998 Isolation and characterization of complementary DNAs encoding human manganese-containing superoxide dismutase. FEBS Lett 229: 256–260
Mullenbach GT, Tabrizi A, Irvine BD, Bell GI, Tainer JA, Halliwell RA 1988 cDNAs of three glutathione peroxidases: selenocystine incorporation. In: Cerutti P, Fridovich I, McCord JM (eds) Oxy-radicals in Molecular Biology and Pathology. Alan R. Liss, New York, pp 313–326
Freeman BA, Young SL, Crapo JD 1983 Liposome-mediated augmentation of superoxide dismutase in endothelial cells presents oxygen injury. J Biol Chem 258: 12534–12542
Michiels C, Raes M, Houbion A, Remacle J 1991 Association of antioxidant systems in the protection of human fibroblasts against oxygen derived free radicals. Free Radic Res Commun 14: 323–334
Michiels C, Raes M, Toussaint O, Remacle J 1994 Importance of Se-glutathione peroxidase, catalase and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med 17: 235–248
Beckam JS, Freeman BA 1986 Antioxidant enzymes as mechanic probes of oxygen-dependent toxicity. In: Taylor AE, Matalon S, Ward P (eds) Physiology of Oxygen Radicals. American Physiological Society, Bethesda, pp 39–53
Bursell SE, Clermont AC, Aiello LP, Aiello LM, Schlossman DK, Feener EP, Laffel L, King GL 1999 High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 22: 1245–1251
Upritchard JE, Sutherland WH, Mann JI 2000 Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammation activity in type 2 diabetes. Diabetes Care 23: 733–738
Jain SK, McVie R, Smith T 2000 Vitamin E supplementation restores glutathione and malonildialdehyde to normal concentrations in erythrocytes of type 1 diabetic children. Diabetes Care 23: 1389–1394
Astley S, Langrish-Smith A, Southon S, Sampson M 1999 Vitamin E supplementation and oxidative damage to DNA and plasma LDL in type 1 diabetes. Diabetes Care 22: 1626–1631
Marchioli R, Schweiger C, Levantesi G, Gavazzi L, Valagussa F 2001 Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data. Lipids 36: S53–S63
Cuzzocrea S, Riley DP, Caputi AP, Salvemini D 2001 Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 53: 135–159
Ceriello A 2003 New insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapy. Diabetes Care 26: 1589–1596
Venugopal SK, Devaraj S, Yang T, Jialal I 2002 Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycaemic conditions via inhibition of protein kinase C-alpha. Diabetes 51: 3049–3054
Abiko T, Abiko A, Clermont AC, Shoelson B, Horio N, Takahashi J, Adamis AP, King GL, Bursell SE 2003 Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: role of oxidants and protein kinase-C activation. Diabetes 52: 829–837
Jain SK 1999 Should high-dose vitamin E supplementation be recommended to diabetic patients?. Diabetes Care 22: 1242–1244
Acknowledgements
We acknowledge the editorial assistance provided by Antonella Bascelli. We also thank the Regional Juvenile Diabetes Association (AGDA) and in particular Mrs. Doriana D'Alimonte D'Attilio for support in childhood diabetes care and research.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by a grant of Italian Ministry of Research (grant COFIN) and a generous donation by Fondazione Carlo Erba, Italy.
Rights and permissions
About this article
Cite this article
Chiarelli, F., Santilli, F., Sabatino, G. et al. Effects of Vitamin E Supplementation on Intracellular Antioxidant Enzyme Production in Adolescents with Type 1 Diabetes and Early Microangiopathy. Pediatr Res 56, 720–725 (2004). https://doi.org/10.1203/01.PDR.0000141990.12375.13
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/01.PDR.0000141990.12375.13
This article is cited by
-
Vitamine für das Auge?
Der Ophthalmologe (2009)
-
Oxidizing and reducing responses in type 1 diabetic patients determined up to 5 years after the clinical onset of the disease
Acta Diabetologica (2008)
-
Ras modulation of superoxide activates ERK-dependent fibronectin expression in diabetes-induced renal injuries
Kidney International (2006)
